{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:52:30Z","timestamp":1788310350159,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.cancergen.2014.01.004","type":"journal-article","created":{"date-parts":[[2014,1,17]],"date-time":"2014-01-17T14:45:44Z","timestamp":1389969944000},"page":"19-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants"],"prefix":"10.1016","volume":"207","author":[{"given":"Cathy C.","family":"Laurie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia A.","family":"Laurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Smoley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin E.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Flinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke L.","family":"Fridley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey A.","family":"Greisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Gribben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane F.","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Paietta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Schaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Tallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Weinshilboum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil E.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tait D.","family":"Shanafelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2014.01.004_bib1","unstructured":"SEER. US Estimated 33-Year L-D Prevalence Counts on 1\/1\/2008. In: Surveillance Epidemiology, and End Results (SEER) Program, National Cancer Institute, DCCPS, Surveillance Research Program, Statistical Research and Applications Branch, released April 2011, based on the November 2010 SEER data submission,\u00a02011. http:\/\/seer.cancer.gov\/."},{"key":"10.1016\/j.cancergen.2014.01.004_bib2","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.01.004_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJMoa0806122","article-title":"B-cell clones as early markers for chronic lymphocytic leukemia","volume":"360","author":"Landgren","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2014.01.004_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/leu.2009.287","article-title":"Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management","volume":"24","author":"Shanafelt","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.cancergen.2014.01.004_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0268-960X(05)80013-X","article-title":"Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia","volume":"8","author":"Oscier","year":"1994","journal-title":"Blood Rev"},{"key":"10.1016\/j.cancergen.2014.01.004_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2011.02.002","article-title":"Importance of genetics in chronic lymphocytic leukemia","volume":"25","author":"Zenz","year":"2011","journal-title":"Blood Rev"},{"key":"10.1016\/j.cancergen.2014.01.004_bib7","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2014.01.004_bib8","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.1158\/1078-0432.CCR-11-0785","article-title":"The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia","volume":"17","author":"Ouillette","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2014.01.004_bib9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3324\/haematol.2010.039768","article-title":"Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia","volume":"96","author":"Gunnarsson","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.cancergen.2014.01.004_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cancergencyto.2010.09.003","article-title":"Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy","volume":"203","author":"Kay","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2014.01.004_bib11","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1182\/blood.V85.12.3610.bloodjournal85123610","article-title":"Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses","volume":"85","author":"Bentz","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.01.004_bib12","doi-asserted-by":"crossref","first-page":"670","DOI":"10.2353\/jmoldx.2010.090192","article-title":"Array comparative genomic hybridization detects chromosomal abnormalities in hematological cancers that are not detected by conventional cytogenetics","volume":"12","author":"Shao","year":"2010","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.cancergen.2014.01.004_bib13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2353\/jmoldx.2010.090118","article-title":"Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays","volume":"12","author":"Hagenkord","year":"2010","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.cancergen.2014.01.004_bib14","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2010-12-327858","article-title":"Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia","volume":"118","author":"Ouillette","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.01.004_bib15","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.cancergen.2014.01.004_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cancergen.2014.01.004_bib17","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cancergen.2014.01.004_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive genomic rearrangement acquired in a single catastrophic event during cancer development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cancergen.2014.01.004_bib19","doi-asserted-by":"crossref","first-page":"4783","DOI":"10.1182\/blood-2012-04-423517","article-title":"High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations","volume":"120","author":"Edelmann","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.01.004_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1200\/JCO.2006.08.0762","article-title":"Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997","volume":"25","author":"Flinn","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2014.01.004_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1200\/JCO.2006.08.3089","article-title":"Comprehensive assessment of genetic and molecular features predicting outcome\u00a0in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997","volume":"25","author":"Grever","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2014.01.004_bib22","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1101\/gr.5402306","article-title":"High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping","volume":"16","author":"Peiffer","year":"2006","journal-title":"Genome Res"},{"key":"10.1016\/j.cancergen.2014.01.004_bib23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/hmg\/ddq003","article-title":"Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis","volume":"19","author":"Conlin","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.cancergen.2014.01.004_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajhg.2010.06.002","article-title":"Mosaic uniparental disomies and aneuploidies as large structural variants of the human genome","volume":"87","author":"Rodriguez-Santiago","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.cancergen.2014.01.004_bib25","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ng.2271","article-title":"Detectable clonal mosaicism from birth to old age and its relationship to cancer","volume":"44","author":"Laurie","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2014.01.004_bib26","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/gepi.20516","article-title":"Quality control and quality assurance in genotypic data for genome-wide association studies","volume":"34","author":"Laurie","year":"2010","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.cancergen.2014.01.004_bib27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2141.2003.04265.x","article-title":"Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukaemia","volume":"121","author":"Dewald","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergen.2014.01.004_bib28","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1101\/gr.092759.109","article-title":"Circos: an information aesthetic for comparative genomics","volume":"19","author":"Krzywinski","year":"2009","journal-title":"Genome Res"},{"key":"10.1016\/j.cancergen.2014.01.004_bib29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.semcancer.2010.10.012","article-title":"New insights into the pathogenesis of chronic lymphocytic leukemia","volume":"20","author":"Klein","year":"2010","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.cancergen.2014.01.004_bib30","doi-asserted-by":"crossref","first-page":"22552","DOI":"10.1073\/pnas.1017092108","article-title":"L3MBTL1 polycomb protein, a candidate tumor suppressor in del(20q12) myeloid disorders, is essential for genome stability","volume":"107","author":"Gurvich","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cancergen.2014.01.004_bib31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1200\/JCO.2010.31.1175","article-title":"Unraveling the molecular pathophysiology of myelodysplastic syndromes","volume":"29","author":"Bejar","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cancergen.2014.01.004_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/ng.788","article-title":"Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia","volume":"43","author":"Yan","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergen.2014.01.004_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2011-01-331678","article-title":"Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression","volume":"118","author":"Klampfl","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.01.004_bib34","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1182\/blood-2011-03-342485","article-title":"Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997","volume":"118","author":"Smith","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2014.01.004_bib35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1056\/NEJMoa075290","article-title":"Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia","volume":"359","author":"Rawstron","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cancergen.2014.01.004_bib36","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1182\/blood-2011-05-357251","article-title":"General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL","volume":"118","author":"Fazi","year":"2011","journal-title":"Blood"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776214000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776214000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:59Z","timestamp":1761896339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776214000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S2210776214000222"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2014.01.004","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2014.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}